Condition 101 content is not available at this time, but we are continually updating the site. Please check back.

However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.

  • Condition: Neuroendocrine Carcinoma of the Uterine Cervix
  • Journal: International journal of surgical oncology
  • Treatment Used: Surgery Plus Adjuvant Chemoradiotherapy (CRT)
  • Number of Patients: 453
  • Published —
This study evaluated the survival of patients with neuroendocrine cancer of the cervix.
  • Condition: Locally Advanced Neuroendocrine Cancer of the Cervix
  • Journal: Anticancer research
  • Treatment Used: Surgery after Chemotherapy
  • Number of Patients: 7
  • Published —
The study researched treatment of locally advanced neuroendocrine cancer of the cervix.
Clinical Trial
  • Status: Recruiting
  • Intervention Type: Other
  • Participants: 5000
  • Start Date: January 1, 2018
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Clinical Trial
  • Status: Active, not recruiting
  • Phase: Phase 1/Phase 2
  • Intervention Type: Drug
  • Participants: 62
  • Start Date: July 30, 2015
A Phase I/II Trial of Topotecan With VX-970 (M6620), an ATR Kinase Inhibitor in Small Cell Cancers